1. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome;Rosário;BMC Med,2013
2. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning;Shoenfeld;Autoimmun Rev,2020
3. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease;Gabay;Ann Rheum Dis,2018
4. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality;Zhang;Int J Antimicrob Agents,2020
5. National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. recommendations for COVID-19 clinical management;Nicastri;Infect Dis Rep,2020